Clinical Trial Update: Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical study of DA-020 for chemotherapy-induced alopecia is not yet recruiting, sponsored by Applied Biology, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Alopecia

Drugs mentioned

• DA-020

Snippet

Sponsor: Applied Biology, Inc. | Conditions: Chemotherapy Induced Alopecia, Chemotherapy Side Effects | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING